Early Recognition and Emergency Treatment of Sepsis and Septic Shock in Children

Kristel W E Hilarius1,2, Peter W Skippen3,4,5, Niranjan Kissoon6,7,8

  • 1Clinical Fellow, Department of Pediatrics, Division of Critical Care Medicine, Vancouver, British Columbia, Canada.

Pediatric Emergency Care
|February 4, 2020
PubMed

Insights

Early recognition and treatment of pediatric sepsis and septic shock are crucial for better outcomes. This approach focuses on rapid identification and management bundles for improved care in emergency settings.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Diseases
  • Critical Care

Background:

  • Sepsis diagnosis in children is challenging due to non-specific symptoms and lack of definitive tests.
  • Early diagnosis is often presumptive, relying on clinical suspicion of infection and systemic changes, especially in immunocompromised children.
  • Prompt recognition, resuscitation, and treatment within the initial hours of presentation are critical for improved patient outcomes.

Purpose of the Study:

  • To outline the contemporary approach to the initial management of sepsis in children presenting to emergency departments.
  • To emphasize the importance of early recognition and intervention strategies.

Main Methods:

  • Utilizing a "recognition bundle" for rapid identification of sepsis.
  • Implementing a "resuscitation and stabilization bundle" to ensure adherence to best practices.
  • Employing a "performance bundle" to address and overcome barriers to optimal care.

Main Results:

  • Quality improvement initiatives using these bundles have consistently shown enhanced care processes.
  • These approaches have demonstrated improved patient outcomes in sepsis management.
  • The bundles facilitate a structured and evidence-based approach to initial sepsis care.

Conclusions:

  • A systematic approach using recognition, resuscitation, and performance bundles improves sepsis care in children.
  • Early, presumptive treatment based on clinical suspicion is often necessary and beneficial.
  • Continuous quality improvement efforts are vital for optimizing sepsis management in pediatric emergency settings.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
160
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
230
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
218
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
195
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
186
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
205